Amphastar Pharmaceuticals (AMPH) Current Taxes (2016 - 2025)
Historic Current Taxes for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $5.6 million.
- Amphastar Pharmaceuticals' Current Taxes rose 33973.46% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 33973.46%. This contributed to the annual value of $9.7 million for FY2024, which is 50062.15% up from last year.
- Latest data reveals that Amphastar Pharmaceuticals reported Current Taxes of $5.6 million as of Q3 2025, which was up 33973.46% from $1.0 million recorded in Q2 2025.
- In the past 5 years, Amphastar Pharmaceuticals' Current Taxes registered a high of $31.1 million during Q3 2023, and its lowest value of $597000.0 during Q2 2022.
- Its 5-year average for Current Taxes is $7.4 million, with a median of $4.6 million in 2022.
- Per our database at Business Quant, Amphastar Pharmaceuticals' Current Taxes surged by 286415.41% in 2023 and then crashed by 9588.0% in 2024.
- Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Current Taxes stood at $9.1 million in 2021, then plummeted by 49.66% to $4.6 million in 2022, then plummeted by 64.8% to $1.6 million in 2023, then surged by 500.62% to $9.7 million in 2024, then crashed by 41.71% to $5.6 million in 2025.
- Its Current Taxes was $5.6 million in Q3 2025, compared to $1.0 million in Q2 2025 and $15.1 million in Q1 2025.